Database Reference
In-Depth Information
1: AA FREQ
2: AS FREQ
3: SS FREQ
4: A FREQ
5: S FREQ
1.
1:
2:
3:
4
4:
1
4
4
4
5:
1
1
1
1:
2:
0.5
3:
4:
5:
2
2
2
1:
2
5
5
5
5
2:
3:
4:
3
3
3
3
0
0.00
5:
250.00
500.00
750.00
1000.00
Years
10:52 AM
Tue, Dec 17, 2002
Fig. 4.13
1: TOTAL SUSC
2: INFECTED
3: TOTAL IMMUNE
1:
160
2:
60
3:
2
1
1
2
2
2
1
2
1:
130
2:
45
3:
2
1
3
3
3
3
1:
100
2:
30
3:
1
0.00
250.00
500.00
750.00
1000.00
Years
Fig. 4.14
2. In this model, how would you reflect the effects of mosquito repellents and
malaria prophylaxis medication, which we investigated in Section 4.1?
3. Reformulate the model to reflect different age cohorts and introduce different
age-specific recovery rates from malaria. What are the effects on the prevalence
of malaria and sickle cell anemia?
4. If the vector and its infection level were included, would this affect the results?
Would this allow the model to be used on other populations, such as those that
do not have an endemic malaria problem?
